Zydus receives final approval from the USFDA for Diclofenac

Zydus Lifesciences Limited has received final approval from the USFDA to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg.

Related Keywords

Ahmedabad , Gujarat , India , United States , Moraiya , , Zydus Lifesciences , Drug Administration , Diclofenac Sodium , Misoprostol Delayed Release , Lifesciences Limited , United States Food , Misoprostol Delayed Release Tablets , Delayed Release Tablets , Zydus Lifesciences Limited ,